AI assistant
Sending…
Sleep Number Corp — Director's Dealing 2025
May 21, 2025
33589_dirs_2025-05-21_0173934b-adf0-4e7a-88a3-a369c89be875.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sleep Number Corp (SNBR)
CIK: 0000827187
Period of Report: 2025-04-28
Reporting Person: Skogerboe Tanya C. (SVP, Chief Supply Chain)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 47877 | Direct |
| Common Stock | 2517.4642 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $18.81 | 2026-03-22 | Common Stock (547) | Direct | |
| Employee Stock Option (Right to Buy) | $23.61 | 2027-03-21 | Common Stock (977) | Direct | |
| Employee Stock Option (Right to Buy) | $34.35 | 2028-03-21 | Common Stock (540) | Direct | |
| Employee Stock Option (Right to Buy) | $47.00 | 2029-03-29 | Common Stock (1240) | Direct | |
| Employee Stock Option (Right to Buy) | $35.68 | 2030-03-15 | Common Stock (1925) | Direct | |
| Employee Stock Option (Right to Buy) | $146.97 | 2031-03-15 | Common Stock (755) | Direct | |
| Employee Stock Option (Right to Buy) | $61.66 | 2032-03-15 | Common Stock (1740) | Direct | |
| Employee Stock Option (Right to Buy) | $28.41 | 2033-03-15 | Common Stock (3035) | Direct |
Footnotes
F1: Includes 38,278 Restricted Stock Units that vest over time.
F2: This Stock Option is fully vested and exercisable.
F3: This Stock Option becomes exercisable with respect to 1/3 of the shares on each of 3/15/24, 3/15/25 and 3/15/26.
More from Sleep Number Corp
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24